Literature DB >> 25765848

Salvage radical prostatectomy after external beam radiation therapy: a systematic review of current approaches.

Deliu Victor Matei1, Matteo Ferro, Barbara Alicja Jereczek-Fossa, Giuseppe Renne, Nicolae Crisan, Danilo Bottero, Claudia Mazzarella, Daniela Terracciano, Riccardo Autorino, Ottavio De Cobelli.   

Abstract

BACKGROUND: Radical external beam radiotherapy (EBRT) is a standard treatment for prostate cancer patients. Despite this, the rate of intraprostatic relapses after primary EBRT is still not negligible. There is no consensus on the most appropriate management of these patients after EBRT failure. For these patients, local salvage therapy such as radical prostatectomy, cryotherapy, and brachytherapy may be indicated.
OBJECTIVE: The objectives of this review were to analyze the eligibility criteria for careful selection of appropriate patients and to evaluate the oncological results and complications for each method.
METHODS: A review of the literature was performed to identify studies of local salvage therapy for patients who had failed primary EBRT for localized prostate cancer.
RESULTS: Most studies demonstrated that local salvage therapy after EBRT may provide long-term local control in appropriately selected patients, although toxicity is often significant.
CONCLUSIONS: Our results suggest that for localized prostate cancer recurrence after EBRT, the selection of a local treatment modality should be made on a patient-by-patient basis. An improvement in selection criteria and an integrated definition of biochemical failure for all salvage methods are required to determine which provides the best oncological outcome and least comorbidity.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 25765848     DOI: 10.1159/000371893

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  9 in total

Review 1.  [Pathogenesis of urological complications after radiation therapy].

Authors:  Y Tolkach; G Kristiansen
Journal:  Urologe A       Date:  2017-03       Impact factor: 0.639

2.  Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System.

Authors:  Seena Safavy; Ramzi B Jabaji; Sharon M Lu; Jeff M Slezak; Harry A Cosmatos; Stephen G Williams; David S Finley
Journal:  Perm J       Date:  2019

Review 3.  Management Options for Biochemically Recurrent Prostate Cancer.

Authors:  Farhad Fakhrejahani; Ravi A Madan; William L Dahut
Journal:  Curr Treat Options Oncol       Date:  2017-05

4.  Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes.

Authors:  Brecht Devos; Walid Al Hajj Obeid; Colin Andrianne; Romain Diamand; Alexandre Peltier; Wouter Everaerts; Hein Van Poppel; Roland Van Velthoven; Steven Joniau
Journal:  World J Urol       Date:  2019-01-21       Impact factor: 4.226

5.  Comparing open and robotic salvage radical prostatectomy after radiotherapy: predictors and outcomes.

Authors:  Pablo F Martinez; Agustin Romeo; Ignacio Tobia; Mariana Isola; Carlos R Giudice; Wenceslao A Villamil
Journal:  Prostate Int       Date:  2020-08-02

6.  Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.

Authors:  Gregory T Chesnut; Amy L Tin; Arjun Sivaraman; Toshikazu Takeda; Taehyoung Lee; Jonathan Fainberg; Nicole Benfante; Daniel D Sjoberg; Hebert Alberto Vargas; Samson W Fine; Peter T Scardino; James A Eastham; Jonathan A Coleman; Karim A Touijer; Michael J Zelefsky; Behfar Ehdaie
Journal:  Urol Oncol       Date:  2021-02-12       Impact factor: 2.954

Review 7.  Salvage local therapy for radiation-recurrent prostate cancer - where are we?

Authors:  Romuald Zdrojowy; Janusz Dembowski; Bartosz Małkiewicz; Krzysztof Tupikowski; Wojciech Krajewski
Journal:  Cent European J Urol       Date:  2016-07-04

8.  Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.

Authors:  Aurélie Mbeutcha; Laurent Chauveinc; Pierre-Yves Bondiau; Marie-Eve Chand; Matthieu Durand; Daniel Chevallier; Jean Amiel; Daniel Lam Cham Kee; Jean-Michel Hannoun-Lévi
Journal:  Radiat Oncol       Date:  2017-03-09       Impact factor: 3.481

9.  Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis.

Authors:  Stephanie Markovina; Marshall W Meeks; Shahed Badiyan; Joel Vetter; Hiram A Gay; Alethea Paradis; Jeff Michalski; Gurdarshan Sandhu
Journal:  Adv Radiat Oncol       Date:  2017-12-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.